Purchase Order HHSN261201700672P
Award Date 9/18/17
Potential Completion Date 12/6/17
Potential Value $23K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Boston, MA 02115, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Cancer Institute awarded a purchase order to Brigham & Women's Hospital Inc. valued at $19,176.00 on February 19, 2020, to select and aliquot plasma samples from 39 cases and 39 matched controls, and separately from 32 cases and 32 matched controls. Performance occurs at the hospital's Department of Faulkner Pathology in Boston, Massachusetts. The order carries firm fixed-price pricing with an ultimate completion date of February 23, 2021. This purchase order was issued to...
- The National Cancer Institute awarded a purchase order to Brigham & Women's Hospital Inc., Department of Faulkner Pathology, for $10,829.00 on June 3, 2013, with final completion on June 2, 2014. The order is firm fixed price with no set-aside. Performance occurs in Boston, Massachusetts. The work involves aliquotting plasma samples from the Health Professionals Follow-Up Study and Nurses' Health Study to support a pooled investigation of adiponectin and multiple myeloma in the NCI Cohort...
- This is a firm fixed price delivery order contract awarded by the National Cancer Institute (NCI), part of the Department of Health and Human Services, to Brigham & Women's Hospital, Inc. The $143,587.50 contract supports the Cancer Genome Atlas (TCGA) program's effort to collect tissue samples and data from various types of cancer. The award is funded through the American Recovery and Reinvestment Act (ARRA) and does not have a small business set-aside designation. Brigham & Women's...
- <p>The National Cancer Institute awarded a purchase order to The Children's Hospital Corporation (doing business as Boston Children's Hospital) valued at $14,964.00 on September 17, 2018, with a firm fixed price structure and ultimate completion date of October 1, 2019. Place of performance is Bethesda, Maryland. The order carries no set-aside designation.</p>
- The National Cancer Institute awarded a purchase order to Dana-Farber Cancer Institute, Inc. for germline DNA samples and data from renal cell carcinoma patients supporting the National Cancer Institute's Renal Cell Carcinoma Genome-Wide Association Study, with a ceiling value of $18,000.00 and an award date of April 10, 2019. Work is performed in Boston, Massachusetts under firm fixed-price terms, with ultimate completion on April 9, 2020. The purchase order procures biological specimens and...
- <p>The National Cancer Institute awarded a purchase order to Trustees of Boston University for $24,840 on September 15, 2017. The order, a firm fixed price acquisition with no set-aside, is for work to be performed in Rockville, Maryland, with an ultimate completion date of September 21, 2018.</p>
- This is a firm fixed price delivery order contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to Brigham & Women's Hospital Inc. for the Cancer Genome Atlas (TCGA) program. The $63,000 award supports the collection of tissue samples and data from various cancer types for the TCGA program, which is funded under the American Recovery and Reinvestment Act (ARRA). Brigham & Women's Hospital is a major academic medical center...
- <p>The National Cancer Institute issued a purchase order to The Broad Institute, Inc. for $13,480.01 on January 24, 2019, for custom lab work on a genomics platform. Work is performed in Cambridge, Massachusetts. The order is firm fixed-price with an ultimate completion date of July 25, 2019. No set-aside was used.</p>
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $13,950 purchase order to Intera Oncology Inc. for laboratory equipment. The firm fixed price contract has a period of performance from September 6, 2023 through October 28, 2023 and will be performed in Wellesley Hills, Massachusetts. No additional details were provided regarding the specific laboratory equipment being procured. The National Cancer Institute conducts and supports...
- <p>The National Cancer Institute awarded a purchase order to Biocytogen LLC for $10,000.00 on April 3, 2018. Work is performed in Worcester, Massachusetts. The order carries a firm fixed price for commercial items, with ultimate completion on May 3, 2018. No small business set-aside was applied.</p>
The National Cancer Institute issued a purchase order to Brigham & Women's Hospital Inc., doing business as Department Of Faulkner Pathology, for $23,450 in ovarian cancer tissue blocks, awarded September 18, 2017, with completion by December 6, 2017. Work is performed in Boston, Massachusetts. The order is firm fixed price with no set-aside.
Generated 8/1/26, 10:40 AM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Purchase of Ovarian Cancer Tissue Blocks from the Nurses Health Study | N02CO72732-95 | Department of Health and Human Services National Institutes of Health | Award Notice 1/1 | 9/14/17, 1:55 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.5k | 9/17/17 |